Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $62.05 | Total: $310.25 |
| 1 | 10 | $52.56 | Total: $525.60 |
| 1 | 25 | $44.53 | Total: $1,113.25 |
| 1 | 50 | $37.96 | Total: $1,898.00 |
| 1 | 100 | $32.85 | Total: $3,285.00 |
Overview
PI3K?-IN-3 (TC KHNS 11) is a PI3K? inhibitor with an IC50 value of 9 nM.PI3K?-IN-3 has a favorable pharmacokinetic profile and inhibits B cell function.
Chemical Properties
| Molecular Formula | C28H24N6O3 |
| Molecular Weight | 492.53 |
| CAS Numbers | 1431540-99-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(=O)(C=1C=C(C=2C3=C(C=CC(=C3)C=4C=C(C#N)C(OC)=NC4)N=CN2)C=CC1)N5CCN(C(C)=O)CC5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Hoegenauer K, et al. Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Med Chem Lett. 2016 Jun 2;7[8] 762-7.